Verition Fund Management LLC
Position in MLTX — MoonLake Immunotherapeutics
CIK 1454027
GREENWICH, CT
Position in MLTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,032,275
+$2,076,529 QoQ
Shares Held
207,102
-24.1% QoQ
Ownership
0.243%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#48
of 172 holders
Holding Since
Mar 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MLTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Verition Fund Management LLC holds $156,064,619 across 64 Biotechnology names. MLTX ranks #10 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
438,746 | $30,997,404 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
|
159,256 | $21,138,048 | |
| 3 | ABVX |
Abivax S.A.
|
105,791 | $14,097,708 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
184,054 | $6,859,692 | |
| 5 | SNDX |
Syndax Pharmaceuticals Inc
|
304,939 | $6,665,966 | |
| 6 | MRVI |
Maravai Lifesciences Holdings, Inc.
|
777,738 | $4,853,085 | |
| 7 | CYTK |
Cytokinetics Inc
|
54,889 | $4,675,993 | |
| 8 | RPRX |
Royalty Pharma plc
|
75,000 | $4,205,250 |
All Filings in MLTX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,032,275 | 207,102 | Shares | Sole | 2026-08-14 | |
| 2025-09-30 | $1,955,746 | 272,768 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,110,474 | 23,527 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $950,065 | 24,317 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||